Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
fda
8
×
life sciences
national blog main
clinical trials
boston top stories
san francisco blog main
cancer
deals
europe blog main
investing
ipo
new york blog main
new york top stories
boston
cancer drugs
europe top stories
national
national top stories
san diego blog main
san diego top stories
san francisco top stories
startups
akouos
biogen
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
covid-19
deerfield management
detroit blog main
detroit top stories
drug discovery
gilead sciences
indiana blog main
indiana top stories
melinta therapeutics
novartis
What
ipo
8
×
medicines
developing
new
therapeutics
biotech
drug
raised
bio
companies
company
covid
fda
million
plans
research
roundup
treat
acquisitions
activity
affects
americans
announced
approvals
approved
arrival
biogen
black
brings
cancer
ceo
clamped
clinic
collabs
company’s
course
daniel
date
days
deal
Language
unset
8
×
Current search:
ipo
×
unset
×
fda
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds